Powrót do wyszukiwania
BK
Zapytanie ofertowe nr 24 04 2026 IM - Risk Evaluation and Control Strategy for Impurities in Support of IMPD Preparation
| Zamawiający | RYVU THERAPEUTICS S.A. |
|---|---|
| Miasto | Kraków |
| Region | małopolskie |
| ID zewnętrzne | 274994 |
| Szacunkowa wartość | - |
|---|---|
| Data publikacji | 24.04.2026 |
| Termin składania ofert | 04.05.2026 23:59 |
| Kody CPV | - |
Opis zamówienia
Risk Evaluation and Control Strategy for Impurities in Support of IMPD Preparation
Detailed impurities control evaluation services related to the proprietary clinical phase 1-suitable API manufacturing process:
1. Mutag
Detailed impurities control evaluation services related to the proprietary clinical phase 1-suitable API manufacturing process:
1. Mutag